Rigidifying cancer cells for better immunotherapy
EPFL scientists have found that stiffening the membranes of cancer cells can lead to improved immunotherapy outcomes. Preclinical tests show that it can increase long-term survival rates to nearly 50%.
Dec 7, 2021
0
83